期刊文献+

利用免疫抑制小鼠模型检测真菌病毒对黄曲霉菌致病力影响 被引量:1

Mycoviruses affect the virulence of Aspergillus flavus to immunosuppressed mouse model
原文传递
导出
摘要 【目的】构建用于比较黄曲霉(Aspergillus flavus,A.flavus)菌株之间致病力差异的小鼠感染模型,并利用该模型评价真菌病毒AfPV1对宿主A.flavus致病力的影响。【方法】用不同浓度环磷酰胺腹腔注射Institute of Cancer Research(ICR)小鼠,根据白细胞的数量判断小鼠免疫抑制程度;通过滴鼻和尾静脉两种感染方法接种不同浓度的A.flavus孢子量,统计14 d以内小鼠的死亡率,确定A.flavus最佳的孢子接种量;通过小鼠组织的菌落负荷量以及肺部组织的病理观察,确定A.flavus感染是否成功;最后利用该小鼠模型评价真菌病毒AfPV1对寄主A.flavus致病力的影响。【结果】腹腔注射环磷酰胺的浓度为250 mg/kg时,能够达到免疫抑制水平;小鼠组织真菌负荷和病理组织切片观察显示A.flavus成功感染接种的ICR小鼠组织;在滴鼻接种模型中,A.flavus的孢子接种量为40μL(1×10^(6) CFU/mL)时比较合适评价A.flavus菌株之间的差异;在尾静脉接种的模型中,A.flavus的孢子接种量在50μL(1×10^(6) CFU/mL)比较合适评价A.flavus菌株之间的差异;病毒AfPV1能够引起A.flavus的致病力下降,但是不影响A.flavus在小鼠肺部的定殖量。【结论】本研究构建的小鼠感染模型能够评价A.flavus菌株之间致病力的差异;真菌病毒AfPV1的感染降低了宿主A.flavus的致病力。 [Objective]To compare the virulence of different Aspergillus flavus strains and the effect of the mycovirus AfPV1 on A.flavus virulence to the established immunosuppressed mouse model.[Methods]Institute of Cancer Research(ICR)mice were intraperitoneally injected with different concentrations of cyclophosphamide,and the degree of immunosuppression was determined based on the number of white blood corpuscles.Different concentrations of A.flavus spores were inoculated through nasal drip and caudal vein,and the optimal inoculation amount of A.flavus spores was determined based on the mortality rate of mice within 14 days.Fungal load and pathological changes of lung tissue were employed to determine whether the mice were infected by A.flavus.The effect of AfPV1 on the virulence of A.flavus was finally evaluated with the mouse model.[Results]The cyclophosphamide at a dose of 250 mg/kg caused the immunosuppression of ICR mice.Fungal load and histological changes demonstrated that ICR mice were successfully infected by A.flavus.In the nasal inoculation model,the inoculation with 40μL(1×10^(6) CFU/mL spores)A.flavus was suitable for the evaluation of A.flavus virulence.In the model of caudal vein inoculation,the suitable inoculation dose of A.flavus was 50μL(1×10^(6) CFU/mL spores).AfPV1 weakened the virulence of A.flavus while did not affect the load of A.flavus in mice.[Conclusion]The constructed mouse infection model could evaluate the pathogenicity of A.flavus strains,and the mycovirus AfPV1 infection reduced the pathogenicity of A.flavus.
作者 杨碧 刘翔 田询 禹文峰 齐晓岚 江银辉 YANG Bi;LIU Xiang;TIAN Xun;YU Wenfeng;QI Xiaolan;JIANG Yinhui(Key Laboratory of Molecular Biology,Guizhou Medical University,Guiyang 550004,Guizhou,China;Key Laboratory of Endemic and Ethnic Diseases,Ministry of Education,Guizhou Medical University,Guiyang 550004,Guizhou,China)
出处 《微生物学报》 CAS CSCD 北大核心 2022年第5期1784-1794,共11页 Acta Microbiologica Sinica
基金 国家自然科学基金(32000017,31660012) 贵州省科技计划(黔科合基础-ZK[2021]重点030,黔科合基础[2019]1277) 贵州省科技厅区域常见疾病与成体干细胞转化研究平台(黔科中引地[2019]4008) 贵州省教育厅(KY[2021]313)。
关键词 Aspergillus flavus 真菌病毒 免疫抑制小鼠 感染模型 尾静脉注射 滴鼻接种 Aspergillus flavus mycovirus immunosuppressed mice infection model caudal vein inoculation nasal inoculation
  • 相关文献

参考文献3

二级参考文献14

  • 1Andes D, Marchillo K, Stamstad T, et al. In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model[J]. Antimicrob Agents Chemother, 2003, 47(10): 3165 - 3169.
  • 2Aneds D M, van Ogtrop M. Characterization and quantitation of the qharmacodynamics of fluconazole in a neutropenic murine disseminated candidiasis infection model [J]. Antimicrob Agents Chemother, 1999, 43(9): 2116-2120.
  • 3Andes D, Craig W A. Animal model pharmacokinetics and pharmacodynamics: a critical review[J]. Int J Antimicrob Agent, 2002, 19(4):261-268.
  • 4Andes D, Marchillo K, Conklin R, et al. Pharmacodynamies of a new triazole, posaconazole, in a routine modal of disseminated eandidiasis[J]. Antimicrob Agents Chemother, 2004, 48 (1): 137 -142.
  • 5Andes D, Marchillo K, Stamstad T, et al. In vivo pharmacodynamics of a new triazole, ravuconazole, in a murine candidiasis model[J]. Antimicrob Agents Chemother, 2003, 47 (4): 1193 - 1199.
  • 6Lewis R E, Prince R A, Chi J D, et al. Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis[J]. Antimicrob Agents Chemother, 2002, 46(10): 3208 - 3214.
  • 7Tansho S, Abe S, Ishibashi H, et al. Efficacy of intravenous itraconazole against invasive pulmonary aspergillosis in neutropenic mice[J]. J Infect Chemother, 2006,12(6): 355 - 362.
  • 8Lewis R E, Liao G L, Hou J G, et al. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis[J]. Antimicrob Agents Chemother, 2007, 51 (4): 1253 - 1258.
  • 9Takemoto K, Yamamoto Y, Ueda Y, et al. Comparative study on the efficacy of AmBisome and Fungizone in a mouse model of pulmonary aspergiUosis[J]. J Antimicrob Chemother, 2006, 57(4): 724-731.
  • 10赵志祥,陈圆,肖敏,陈绵才.宏基因组学:热带冬季瓜菜病害生物防治新策略[J].分子植物育种,2015,13(5):1169-1176. 被引量:1

共引文献17

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部